Wenbin Guo
Second Xiangya Hospital of Central South University · Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha 410011, Hunan, China. · Central South University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Wenbin Guo as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:46 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07813169 · Study on iTBS Regulating the Reward Circuit Function to Improve Anhedonia in DepressionGuo Wenbin · recruiting · Major Depression, Anhedonia, Melancholic Depression · principal investigator
- N/ANCT07444463 · Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical ApplicationsCentral South University · not yet recruiting · Schizophrenia, Bipolar Disorder, Major Depressive Disorder (MDD) · study chair
- N/ANCT06452953 · Modified Suanzaoren Decoction Versus Eszopiclone for the Treatment of Chronic Insomnia DisorderCentral South University · completed · Chronic Insomnia Disorder · principal investigator
- N/ANCT05039489 · A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in SchizophreniaCentral South University · completed · Schizophrenia · principal investigator
- N/ANCT04977232 · Adjunctive Game Intervention for Anhedonia in MDD PatientsCentral South University · completed · Depression · principal investigator
- N/ANCT04218981 · Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental DisordersCentral South University · completed · Common Mental Disorder · study director
- N/ANCT03894085 · Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging (fMRI) Study With Paroxetine TreatmentCentral South University · completed · Anxiety Disorder, Obsessive-Compulsive Disorder · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:46 UTC. The ranking covers the 200 most relevant of 396 PubMed records, and a shared surname and initials can bring in a namesake. All 396 on PubMed
- 379 citationsRCR 11.7
- 302 citationsRCR 8.5
- 280 citationsRCR 17.9
- A multicenter phase II study of ganetespib monotherapy in patients with genotypically defined advanced non-small cell lung cancer.Clin Cancer Res · 2013193 citationsRCR 5.0
- Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study.Hypertension · 2017174 citationsRCR 6.6
- Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding.J Hepatol · 2017168 citationsRCR 8.1
- Safety and dose modification for patients receiving niraparib.Ann Oncol · 2018162 citationsRCR 4.8
- Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices.Hepatology · 1997150 citationsRCR 5.5
- A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients.Int J Radiat Oncol Biol Phys · 2002143 citationsRCR 3.6
- Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumors.J Hematol Oncol · 2021133 citationsRCR 6.3